Table 1b.
Specific Demographics for TLE participants.
| Age | Gender | Handedness | Age of Onset | Side of Focus | MRI Findings | Epilepsy Medications | |
|---|---|---|---|---|---|---|---|
| Pt #1 | 11 | M | R | 9 | L | Hippocampal Sclerosis | Lamotrigine |
| Pt #2 | 9 | F | R | 5 | R | Normal | Valproic Acid |
| Pt #3 | 9 | M | R | 9 | L | Normal | Leviteracetam |
| Pt #4 | 11 | F | R | 7 | R | Normal | Carbamezapine |
| Pt #5 | 11 | F | R | 6 | L | Normal | Lamotrigine |
| Pt #6 | 12 | M | R | 5 | R | Normal | Valproic Acid Leviteracetam |
| Pt #7 | 10 | M | R | 8 | R | Normal | Oxcarbazine Leviteracetam |
| Pt #8 | 10 | F | R | 8 | L | Normal | Carbamezapine |
| Pt #9 | 9 | M | R | 7 | L | Normal | None |
| Pt #10 | 9 | M | R | 3 | R | Normal | None |
| Pt #11 | 15 | M | R | 10 | L | Normal | Perampanel Lacosamide |
| Pt #12 | 12 | M | R | 6 | R | Normal | Oxcarbazine |
| Pt #13 | 8 | F | L | 2 | R | Normal | Leviteracetam Medical Marijuana |
| Pt #14 | 9 | F | R | 7 | R | Normal | Lamotrigine |
| Pt #15 | 12 | F | R | 8 | R | Normal | Oxcarbazine |
Pt = Participant, R = Right, L = Left